Plasma p‐tau217, NfL, GFAP diagnostic performance and biomarker profiles in Alzheimer's disease, frontotemporal dementia, and psychiatric disorders, in a prospective unselected neuropsychiatry memory clinic
Eratne D., Zetterberg H., Blennow K., Santillo A., Loi S., Masters C., Collins S., Li Q., Bhalala O., Lewis C., Dang C., Malpas C., Kang M., Velakoulis D.Plasma p-tau217, NfL, GFAP, Alzheimer's, frontotemporal dementia, psychiatric disorders
| Document type | Article |
| Journal title / Source | Alzheimer's & Dementia |
| Volume | 21 |
| Issue | 10 |
| Publisher's name | Wiley |
| Publisher's address (city only) | Hoboken, NJ, United States |
| Publication date | 2025-1-1 |
| DOI | 10.1002/alz.70717 |
| Language | English |